Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Mazindol, sold under the brand names Mazanor and Sanorex, is an appetite suppressant which is used in the short-term treatment of obesity. It is also used off-label in the treatment of narcolepsy and cataplexy. The drug is taken orally.
Applications & Research
Explore the main themes, entities and connections around Mazindol. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
treatment dat obesity efficacy appetite affinity used drug sert net cataplexy reuptake qsar ring short-term orexin hyperactivity disorder narcolepsy 10
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Mazindol | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Mazindol | AHFS/Drugs.com | Micromedex Detailed Consumer Information | 1.00 | infobox |
| Mazindol | ATC code | A08AA05 (WHO) | 1.00 | infobox |
| Mazindol | Bioavailability | 93% | 1.00 | infobox |
| Mazindol | CAS Number | 22232-71-9 Y | 1.00 | infobox |
| Mazindol | ChEMBL | ChEMBL781 Y | 1.00 | infobox |
| Mazindol | ChemSpider | 3880 Y | 1.00 | infobox |
| Mazindol | Chirality | Racemic mixture | 1.00 | infobox |
| Mazindol | CompTox Dashboard (EPA) | DTXSID1023237 | 1.00 | infobox |
| Mazindol | Drug class | Serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI); Anorectic; Wakefulness-promoting agent; Stimulant | 1.00 | infobox |
| Mazindol | DrugBank | DB00579 Y | 1.00 | infobox |
| Mazindol | ECHA InfoCard | 100.040.764 | 1.00 | infobox |
| Mazindol | Elimination half-life | 10–13 hours | 1.00 | infobox |
| Mazindol | Excretion | Renal | 1.00 | infobox |
| Mazindol | Formula | C16H13ClN2O | 1.00 | infobox |
| Mazindol | IUPHAR/BPS | 4797 | 1.00 | infobox |
| Mazindol | KEGG | D00367 Y | 1.00 | infobox |
| Mazindol | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Mazindol | Legal status | BR: Class B2 (Anorectic drugs) | 1.00 | infobox |
| Mazindol | Legal status | CA: Schedule IV | 1.00 | infobox |
| Mazindol | Legal status | DE: Anlage II (Authorized trade only, not prescriptible) | 1.00 | infobox |
| Mazindol | Legal status | US: Schedule IV | 1.00 | infobox |
| Mazindol | Metabolism | Hepatic | 1.00 | infobox |
| Mazindol | Molar mass | 284.74 g·mol−1 | 1.00 | infobox |
| Mazindol | PubChem CID | 4020 | 1.00 | infobox |
| Mazindol | Routes of administration | Oral | 1.00 | infobox |
| Mazindol | Trade names | Mazanor, Sanorex | 1.00 | infobox |
| Mazindol | UNII | C56709M5NH | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.